Efficacy and Safety of Intramuscular HBIG Grifols for the Prevention of Recurrence After Liver Transplantation
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00895713|
Recruitment Status : Completed
First Posted : May 8, 2009
Last Update Posted : May 8, 2009
Instituto Grifols, S.A.
Information provided by:
Grifols Biologicals Inc.
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Completed|
|Primary Completion Date :||June 2005|
|Study Completion Date :||July 2005|